Filing excerpt
Adjusted Operating EBITDA was $197 million for the three months ended June 30, 2026, up 44% as compared to $137 million for the three months ended June 30, 2025, primarily due to an increase in sales volume, favorable mix and productivity gains, partially offset by increased costs of raw materials inputs and select growth investments in SG&A and R&D.